Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration "DINOSAUR"


Phase 2 Results N/A

Summary of Purpose

The aim of the study is to perform a randomized double-blind placebo controlled prospective study in newborn infants with MRI confirmed Middle Cerebral Artery (MCA) Perinatal Arterial Ischemic Stroke (PAIS) with darbepoetin. It will be investigated whether intravenous administered darbepoetin can induce the formation of neuronal tissue and restore brain function in neonates who suffered from PAIS compared to...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 August 2017.

1 Jul 2017 24 May 2017 1 Oct 2019 1 Apr 2021 1 Aug 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available